Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Indian Patients with Metastatic Colorectal Cancer
NCT03564938Phase 4Completed
- Sponsor
- Bayer
- Start
- Jul 2018
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regorafenib in metastatic colorectal cancer (mCRC), sponsored by Bayer. Started Jul 2018; status: completed.
02
Drugs
regorafenib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03564938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03564938.